These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 7335554

  • 1. Central action of ketotifen.
    Rogóz Z, Skuza G, Sowińska H.
    Pol J Pharmacol Pharm; 1981; 33(5):503-15. PubMed ID: 7335554
    [Abstract] [Full Text] [Related]

  • 2. The central action of salbutamol, a beta-agonist with a potential antidepressant activity.
    Przegalinski E, Baran L, Kedrek G.
    Pol J Pharmacol Pharm; 1980; 32(4):485-93. PubMed ID: 6265886
    [Abstract] [Full Text] [Related]

  • 3. Central action of pirenzepine.
    Rogóz Z, Skuza G, Sowińska H.
    Pol J Pharmacol Pharm; 1981; 33(6):615-26. PubMed ID: 6897118
    [Abstract] [Full Text] [Related]

  • 4. Effects of antihistaminic drugs in tests for antidepressant action.
    Rogóz Z, Skuza G, Sowińska H.
    Pol J Pharmacol Pharm; 1981 Oct; 33(3):321-35. PubMed ID: 6119682
    [Abstract] [Full Text] [Related]

  • 5. Psychopharmacological profile of mesterolone.
    Baran L, Przegaliński E.
    Pol J Pharmacol Pharm; 1981 Oct; 33(3):299-303. PubMed ID: 7198778
    [Abstract] [Full Text] [Related]

  • 6. Mast cell stabilizer ketotifen [4-(1-methyl-4-piperidylidene)-4h-benzo[4,5]cyclohepta[1,2-b]thiophen-10(9H)-one fumarate] prevents mucosal mast cell hyperplasia and intestinal dysmotility in experimental Trichinella spiralis inflammation in the rat.
    Serna H, Porras M, Vergara P.
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1104-11. PubMed ID: 16988056
    [Abstract] [Full Text] [Related]

  • 7. The lack of antidepressant properties and a potent central antiserotonin activity of Org 8282.
    Przegaliński E, Baran L, Siwanowicz J, Rawłów A.
    Pol J Pharmacol Pharm; 1986 Dec; 38(4):377-84. PubMed ID: 3774630
    [Abstract] [Full Text] [Related]

  • 8. The action of compound WA-335 on the central nervous system.
    Maj J, Baran L, Sowińska H, Gancarczyk L.
    Arch Immunol Ther Exp (Warsz); 1976 Dec; 24(2):205-22. PubMed ID: 945051
    [Abstract] [Full Text] [Related]

  • 9. Central action of glaucine in rodents.
    Jagiełło-Wójtowicz E, Kleinrok Z, Jusiak L, Matuszek B, Daniłoś J, Chodakowska A.
    Acta Pol Pharm; 1994 Dec; 51(2):179-84. PubMed ID: 7863789
    [Abstract] [Full Text] [Related]

  • 10. Central effects of Ro 19-6327 given acutely and repeatedly.
    Skuza G, Rogóz Z.
    Pol J Pharmacol Pharm; 1991 Dec; 43(6):437-47. PubMed ID: 1668212
    [Abstract] [Full Text] [Related]

  • 11. On the central antiserotonin action of trazodone.
    Baran L, Maj J, Rogóz Z, Skuza G.
    Pol J Pharmacol Pharm; 1979 Dec; 31(1):25-33. PubMed ID: 482164
    [Abstract] [Full Text] [Related]

  • 12. Central antiserotonergic and antidopaminergic action of pirenperone, a putative 5-HT2 receptor antagonist.
    Pawłowski L, Siwanowicz J, Bigajska K, Przegaliński E.
    Pol J Pharmacol Pharm; 1985 Dec; 37(2):179-96. PubMed ID: 4048012
    [Abstract] [Full Text] [Related]

  • 13. Some central effects of tiflucarbine, a new potential antidepressant drug.
    Maj J, Rogóz Z, Sowińska H, Zalewski Z.
    Pol J Pharmacol Pharm; 1987 Dec; 39(1):63-74. PubMed ID: 2823240
    [Abstract] [Full Text] [Related]

  • 14. The central action of carbamazepine as a potential antidepressant drug.
    Maj J, Chojnacka-Wójcik E, Lewandowska A, Tatarczyńska E, Wiczyńska B.
    Pol J Pharmacol Pharm; 1985 Dec; 37(1):47-56. PubMed ID: 4041037
    [Abstract] [Full Text] [Related]

  • 15. Antiserotonin activity of 9-methyl-2-[3-(4-phenyl-1-piperazinylpropyl)]-1,2,3,4-tetrahydro -beta-carbolin-1-one (B-193).
    Wiczyńska B, Chojnacka-Wójcik E, Rokosz-Pelc A, Mazela H, Przegaliński E.
    Pol J Pharmacol Pharm; 1989 Dec; 41(2):169-81. PubMed ID: 2556691
    [Abstract] [Full Text] [Related]

  • 16. Psychopharmacological profile of dexamisole.
    Przegaliński E, Bigajska K, Siwanowicz J.
    Pol J Pharmacol Pharm; 1980 Dec; 32(1):21-9. PubMed ID: 7454609
    [Abstract] [Full Text] [Related]

  • 17. Central action of phenylethylamine in rats.
    Jagiełło-Wójtowicz E.
    Pol J Pharmacol Pharm; 1981 Dec; 33(1):59-71. PubMed ID: 7196039
    [Abstract] [Full Text] [Related]

  • 18. Central antiserotonin action of fluperlapine.
    Maj J, Chojnacka-Wójcik E, Lewandowska A, Tatarczyńska E.
    Pol J Pharmacol Pharm; 1985 Dec; 37(4):517-24. PubMed ID: 2867538
    [Abstract] [Full Text] [Related]

  • 19. Central effects of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in mice.
    Maj J, Rogóz Z, Skuza G.
    Pol J Pharmacol; 1993 Dec; 45(4):349-60. PubMed ID: 7906989
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and pharmacological properties of N-arylpiperazine-N'-alkylindanes.
    Misztal S, Chojnacka-Wójcik E, Bartyzel P, Moskal A, Tatarczyńska E, Wiczyńska B, Lewandowska A.
    Pol J Pharmacol Pharm; 1984 Dec; 36(6):697-703. PubMed ID: 6336001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.